21.04.2015 • NewsLiquefied Natural Gas (LNG)exportsGas

ExxonMobil President Says Bureaucracy Strangling LNG Exports

The US is at risk of losing economic opportunity and the ability to solidify its role as a global leader in energy production if policymakers do not quickly move to approve liquefied natural gas (LNG) exports, Rob Franklin, president of ExxonMobil Gas & Power Marketing Company, said in a speech at the Johns Hopkins School of Advanced International Studies in Washington DC.

With bureaucracy stalling legislation and issuance of export permits, the US role as world's leading energy producer is at stake, Franklin added. In his view, exports of LNG "should be treated no differently from other exports such as agricultural goods, automobiles and computer products.

"LNG exports can provide the spur to further increase America's natural gas production, providing all the attendant benefits that would generate," the executive said.

ExxonMobil is currently engaged in a $10 billion project to convert the LNG regasification terminal at Golden Pass, Texas, into an LNG export terminal. An application to export to non-Free Trade Agreement countries was submitted to federal officials more than two years ago, but no decision has been made.

Permit applications for some two dozen other projects are also in the same state of "bureaucratic limbo."

As global LNG demand is expected to triple between 2010 and 2040, the amount of incremental gas needed to meet global demand by 2025 will be almost double the size of the entire U.S. gas market today," Franklin said, adding that most of the new demand will come from existing and emerging markets in Asia-Pacific and the Middle East.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.